IR@PKUHSC  > 北京大学第三临床医学院
学科主题临床医学
Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1
Liu Ning1; Xu Ning2; Wei Li-hui3; Chai Guo-lin4
关键词mammalian target of rapamycin osteoclast neurofibromatosis type 1 rapamycin
刊名CHINESE MEDICAL JOURNAL
2013-01-05
DOI10.3760/cma.j.issn.0366-6999.20121227
126期:1页:101-107
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]BONE-RESORPTION ; SCHWANN-CELLS ; NF1 ; GROWTH ; TUMORS ; MOUSE ; IMMUNOSUPPRESSANT ; HYPERACTIVATION ; CHILDREN ; THERAPY
英文摘要

Background Neurofibromatosis type 1 (NF1) is the most common genetic syndrome predisposing patients to various tumors due to dysregulation of the Ras signaling pathway. Recent research has shown NF1 patients also suffer a spectrum of bone pathologies. The pathogenesis of NF1 bone diseases is largely unknown. There is no current treatment. By Nf1 heterozygote (Nf1+/-) mice and Nf1 conditional knockout mice, we and other groups demonstrated abnormal osteoblast and osteoclast function due to dysregulation of Ras signaling. However, the specific downstream effector pathways linked to NF1 abnormal osteoblastogenesis and osteoclastogenesis have not been defined. In this study, we investigated the Ras downstream effector related with NF1 bone disease.

Methods We used Nf1+/+ and Nf1+/- mice as normal and NF1 models. Bone stromal cells extracted from Nf1+/+ and Nf1+/- mice were induced osteoclasts. The osteoclast cell was stained by tartrate resistant acid phosphatase staining. The osteoclast cell number was counted and the surface area of osteoclast cells was calculated under the microscope. The mRNA of mammalian target of rapamycin (mTOR) was determined by quantitative reverse-transcription-polymerase chain reaction. The presence of ribosomal protein S6 kinase was determined by Western blotting.

Results Compared with Nf1+/+ mice, Nf1+/- mice had about 20% more of osteoclast cells. These osteoclast cells were larger in size with more nuclei. Hyperactive mTOR was detected in Nf1+/- osteoclast cells. Inhibition of mTOR signaling by rapamycin in Nf1+/- osteoclasts abrogated abnormalities in cellular size and number.

Conclusion mTOR pathway inhibition may represent a viable therapy for NF1 bone diseases.

语种英语
WOS记录号WOS:000319793700019
项目编号985-2-015-24
资助机构Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China
引用统计
被引频次:3[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/66320
专题北京大学第三临床医学院
作者单位1.Haidian Maternal & Child Hlth Hosp, Beijing 100080, Peoples R China
2.Peking Univ, Hosp 3, Dept Internal Med, Beijing 100191, Peoples R China
3.Peking Univ, Peoples Hosp, Dept Obstet & Gynecol, Beijing 100044, Peoples R China
4.China Japan Friendship Hosp, Dept Hematol, Beijing 100029, Peoples R China
推荐引用方式
GB/T 7714
Liu Ning,Xu Ning,Wei Li-hui,et al. Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1[J]. CHINESE MEDICAL JOURNAL,2013,126(1):101-107.
APA Liu Ning,Xu Ning,Wei Li-hui,&Chai Guo-lin.(2013).Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1.CHINESE MEDICAL JOURNAL,126(1),101-107.
MLA Liu Ning,et al."Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1".CHINESE MEDICAL JOURNAL 126.1(2013):101-107.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu Ning]的文章
[Xu Ning]的文章
[Wei Li-hui]的文章
百度学术
百度学术中相似的文章
[Liu Ning]的文章
[Xu Ning]的文章
[Wei Li-hui]的文章
必应学术
必应学术中相似的文章
[Liu Ning]的文章
[Xu Ning]的文章
[Wei Li-hui]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。